Overview

Onward AssIst is an advanced cancer prognostics platform that
helps oncologists make better treatment decisions and improve
outcomes. The company provides computer vision- and machine
learning-based automated diagnostic tools and treatment decision
support tools for use by histopathologists, radiologists and
oncologists.

Onward AssIst leverages deep-tech to help localize cancer and
reduce unnecessary biopsies. The company partners with clinicians
to build machine learning models that analyze images of new
patients to automatically identify the location of tumors, stroma,
etc., and combine data with other patient-related information to
derive advanced insights on tumor classification and staging.

The company is engaged in continuous innovation and is associated
with cancer institutes with clinical collaborations focused on novel
approaches, challenges faced in cancer prognostics, and important
biomarkers.

Learn More

Find out more about Onward AssIst at https://www.onwardhealth.ai/.